Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels
2006 StandoutNobel
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Bladder and Kidney Cancer Following Cyclophosphamide Therapy for Non-Hodgkin's Lymphoma
1995 Standout
Cancer risk in patients with inflammatory bowel disease
2001 Standout
Testicular Germ-Cell Cancer
1997 Standout
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
2005 Standout
An immune edited tumour versus a tumour edited immune system: prospects for immune therapy of acute myeloid leukaemia
2006
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Platelet functions and clinical effects in acute myelogenous leukemia
2007
Contribution of platelets to tumour metastasis
2011 Standout
Secondary leukemias induced by topoisomerase-targeted drugs
1998
The role of autophagy in neurodegenerative disease
2013 Standout
Hemolytic disease due to membrane ion channel disorders
2004
Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs
2002
Oral Anticoagulant Therapy
2012 Standout
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Neurological aspects of osteopetrosis
2003
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours
1991
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
2004 Standout
DNA topoisomerase II, genotoxicity, and cancer
2007
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels
2013 StandoutNobel
Chronic myelogenous leukemia: A review
1996
Metastasis suppressors alter the signal transduction of cancer cells
2003
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment
2015
Antifungal prophylaxis for severely neutropenic chemotherapy recipients
2002
Nm23-H1 Metastasis Suppressor Phosphorylation of Kinase Suppressor of Ras via a Histidine Protein Kinase Pathway
2002
11q23 balanced chromosome aberrations in treatment‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop†
2002
Apoptosis
2002 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells
1997
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
The Ki-67 protein: From the known and the unknown
2000 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
The pathophysiology and management of thrombotic thrombocytopenic purpura
1996
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
Metastasis-Suppressor Genes: a Review and Perspective on an Emerging Field
2000
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta‐analysis of randomised‐controlled trials
2005
Carcinoma of the Urinary Bladder after Treatment with Cyclophosphamide for Non-Hodgkin's Lymphoma
1988
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
The hereditary stomatocytoses: genetic disorders of the red cell membrane permeability to monovalent cations
2004
Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor–Negative Breast Cancer
2005
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients
2000
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
2003
The Tumor Dormant State
1981
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients
1983 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
The RAD9 Gene Controls the Cell Cycle Response to DNA Damage in Saccharomyces cerevisiae
1988 StandoutScienceNobel
The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis
1985
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
1982 Standout
The nature of adriamycin-induced cytotoxicity in Chinese hamster cells as revealed by premature chromosome condensation.
1975
Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.
1985
Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
2003
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
2000
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Effects of platelet inhibitors on the platelet aggregation induced by plasma from patients with thrombotic thrombocytopenic purpura
1981
Epithelial Carcinoma of the Ovary: Current Strategies
1981
The occurrence of cancer in immune deficiencies
1982
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
2007
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts
2009
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Depressed immunity and the development of cancer.
1981
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients
1984
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
Cultured Human Tumour Cells May Be Arrested In All Stages of the Cycle During Stationary Phase: Demonstration of Quiescent Cells In G1, S and G2 Phase
1984
The incidence of secondary leukemias.
1999
Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview
2007
Cisplatin
1984 Standout
International Staging System for Multiple Myeloma
2005 Standout
Works of Peter Ernst being referenced
Autologous Stem Cell Transplantation As Post-Remission Therapy in Adult Acute Myelogenous Leukemia: Does Platelet Contamination of Peripheral Blood Mobilized Stem Cell Grafts Influence the Risk of Leukemia Relapse?
2000
Effects of cytokine‐mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells
1995
Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the european group for blood and marrow transplantation
1998
Allogeneic bone marrow transplantation for severe post‐splenectomy thrombophilic state in leaky red cell membrane haemolytic anaemia of the stomatocytosis class
2003
The effect of fluconazole as prophylaxis for neutropenic patients on the isolation of Candida spp. from surveillance cultures
1994
Bone Marrow Transplantation for Infantile Malignant Osteopetrosis
1995
Paroxysmal nocturnal hemoglobinuria in pregnancy
2003
Therapy‐related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992
2001
Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with treosulfan (=dihydroxybusulfan)
1980
Perturbation of Generation Cycle of Human Leukaemic Blast Cells in vivo by Daunomycin
1973
EFFECT OF ANTI‐LEUKEMIC DRUGS ON CELL CYCLE OF HUMAN LEUKEMIC BLAST CELLS IN VIVO
1969
Perturbation of Cell Cycle of Human Leukaemic Myeloblasts in vivo by Cytosine Arabinoside
1973
Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: report of the third Workshop of the Molecular Biology/BMT study group.
1991
Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia
2004
Thrombotic Thrombocytopenic Purpura: Treatment with a Combination of Antiplatelet Drugs
1979
Perturbation of Generation Cycle of Human Leukemic Myeloblasts In Vivo by Methotrexate
1971